case_images: PMC11266088_01
case_images: Schematic discription of the treatment protocol.
case_images: fonc-14-1401761-g001.jpg
case_images: PMC11266088_01_fonc-14-1401761-g001.jpg
case_images: f1
case_images: Figure 1 ). Four weeks after the first administration of peginterferon alfa-2a, the vision improved to a small extent and remained stable at last follow-up.
case_images: Swimmer's plot that shows the individual treatment course of each patient from the initial diagnosis until the preparation of the manuscript. The vertical purple line represents the start of cystic Peg Interferon alfa treatment in each patient.
case_images: fonc-14-1401761-g002.jpg
case_images: PMC11266088_01_fonc-14-1401761-g002.jpg
case_images: f2
case_images: Peginterferon alfa-2a treatment in patient 2: high resolution, isotropic, strongly T2-weighted sequences, with 0.7 mm voxel size were acquired at 1.5 T using a Siemens Aera (CISS) and Philips Ingenia (BTFE). The lower panel indicates development of the cyst volume and treatment.
case_images: fonc-14-1401761-g003.jpg
case_images: PMC11266088_01_fonc-14-1401761-g003.jpg
case_images: f3
case_images: The CP cyst remained stable in size for 41 weeks after the completion of the peginteferon alfa-2a therapy (Figure 3).